181698-25-9

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 181698-24-8 (5S,8R)-3,8-dimethyl-5-[(S)-2-hydroxy-1-methylethyl]-1-methoxy-5,6,7,8-tetrahydronaphthalene 
• 181960-78-1 (2S,5R)-2-[(S)-2-(tert-butyldimethylsilyloxy)-1-methylethyl]-5-methylcyclohexan-1-one 
• 181960-77-0 (2S,5R)-2-[(S)-2-(tert-butyldimethylsilyloxy)-1-methylethyl]-5-methylcyclohexan-1-ol 
• 13834-16-7 (1R,2S,5R)-2-[(S)-2-hydroxy-1-methylethyl]-5-methylcyclohexan-1-ol 
• 20549-46-6 (+)-neoisopulegol 
• 404367-05-1 (3R,6S)-6-[(S)-2-(tert-Butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-2-[1,3]dithian-2-ylidene-3-methyl-1-(2-methyl-allyl)-cyclohexanol 
• 181698-23-7 (2S,5R)-2-[(S)-2-(tert-butyldimethylsilyloxy)-1-methylethyl]-6-(1,3-dithian-2-ylidene)-5-methylcyclohexan-1-one 

Downstream Products

• 404366-99-0 (4RS,5S,8R)-3,8-dimethyl-5-[(1S)-1,5-dimethyl-3-phenylsulfonylhex-4-enyl]-1-methoxy-5,6,7,8-tetrahydronaphthalene 

Relevant academic research and scientific papers

Enantiospecific syntheses of pseudopterosin aglycones. Part 2. Synthesis of pseudopterosin K-L aglycone and pseudopterosin A-F aglycone via a B→BA→BAC annulation strategy

The enantiomeric aglycones of pseudopterosins K-L and A-F are synthesised from (-)- and (+)-isopulegol respectively. Key features are (a) the construction of the C3 stereogenic centre by a directed epoxidation-reduction sequence (K-L); (b) the creation of

A synthetic approach to the pseudopterosins

Three Lewis acid catalysed reactions used in a synthesis of the tricyclic core of the marine anti-inflammatory pseudopterosins are reported; the reductive cleavage of an oxirane with inversion, the cyclisation of an α-hydroxy ketenedithioacetal to an aren